Health Condition 1: null- ASA I,II and III patients scheduled for Endoscopic Ultrasound
Conditions
Interventions
Intervention1: ketamine with propofol: single ketamine dose @ 1mg/kg initial bolus, followed by propofol bolus at 2mg/kg continued @ 50 - 200 microgm/kg/min till end of the procedure
Intervention2: pr
Sponsors
ILBS
Eligibility
Inclusion criteria
Inclusion criteria: ASA physical status I,II and III patients scheduled for day care endoscopic ultrasongraphy
Exclusion criteria
Exclusion criteria: Refusal to participate in the study. History of allergy to propofol. Patients having cardiac disease, impaired renal function,uncontrolled hypertension, uncontrolled thyroid dysfunction, patients on antipsychotic medication Pregnant and lactating mothers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary end point of the study is successful completion of endoscopic procedure under sedationTimepoint: The primary end point of the study is successful completion of endoscopic procedure under sedation AT THE END OF THE PROCEDURE. | — |
Secondary
| Measure | Time frame |
|---|---|
| time to discharge within 2 hoursTimepoint: every 15 mins upto 2hous after the procedure | — |
Countries
India
Contacts
Public ContactShweta A Singh
ILBS
Outcome results
None listed